Position in EVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,880
+$3,630 QoQ
Shares Held
12,100
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 34 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. EVO ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
31,338 | $1,086,488 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,350 | $1,070,229 | |
| 3 | ZTS |
Zoetis Inc.
|
14,510 | $1,042,688 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,892 | $1,025,142 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $917,131 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
29,875 | $293,671 | |
| 7 | VTRS |
Viatris Inc
|
11,120 | $176,585 | |
| 8 | YCBD |
cbdMD, Inc.
|
137,621 | $92,618 |
All Filings in EVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,880 | 12,100 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,250 | 12,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $37,268 | 12,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,923 | 12,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $50,820 | 12,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,414 | 12,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,336 | 12,100 | Shares | Sole | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||